Testicular Cancer - Results from #260

Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis. March 1, 2023

Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer. February 24, 2023

From blazing to burnt out: Spontaneous regression of a testicular germ cell tumour. February 23, 2023

Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. February 20, 2023

Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages. February 13, 2023

Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT). February 7, 2023

cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker. February 3, 2023

Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing. February 2, 2023

Age related differences in primary testicular lymphoma: A population based cohort study. January 30, 2023

Primary Retroperitoneal Lymph Node Dissection in Stage I and Low-volume Metastatic Germ Cell Tumors. January 30, 2023

Impact of testicular cancer stage on semen parameters in patients before orchiectomy. January 27, 2023

Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center. January 24, 2023

Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center. January 18, 2023

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy. January 16, 2023

Robot-assisted retroperitoneal lymph node dissection for post-chemotherapy residual mass in testicular cancer: Long-term experience from a tertiary care centre. January 13, 2023

The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit. January 11, 2023

Sperm DNA methylome abnormalities occur both pre- and post-treatment in men with Hodgkin disease and testicular cancer. January 10, 2023

Tumor Marker Decline in Predicting Treatment Outcome among Poor-Risk Testicular Germ Cell Tumors-A Tertiary Cancer Center Data. January 5, 2023

Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial. January 2, 2023

Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence. December 28, 2022

Page 14 of 95